Shilan Liu

Discovery of 8-Amino-imidazo[1,5-<i>a</i>]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis

Jian Liu, Deodial Guiadeen, A. D. Krikorian et al. · ACS Medicinal Chemistry Letters · 2015 · 38 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

&lt;p&gt;Combining data from TCGA and GEO databases and reverse transcription quantitative PCR validation to identify gene prognostic markers in lung cancer&lt;/p&gt;

Xiao Liu, Jun Wang, Mei Chen et al. · OncoTargets and Therapy · 2019 · 35 citations · Full text

Medicine, Molecular Biology, Oncology +17

Comparison of outcomes between laparoscopic and robot-assisted partial nephrectomy for complex renal tumors: RENAL score ≥7 or maximum tumor size &gt;4 cm

Pengxiu Lin, Minhong Wu, Hongyong Gu et al. · Minerva Urology and Nephrology · 2021 · 28 citations

Medicine, Surgery, Urology +17

Discovery of novel BTK inhibitors with carboxylic acids

Xiaolei Gao, James Wang, Jian Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutes

Jian Liu, Deodial Guiadeen, A. D. Krikorian et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 16 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14